Paul D. Dash works in the field of Neurology. He studied medicine at University of California Irvine School of Medicine. University of California Irvine School of Medicine has a rank of 45 in research and a 62 in primary care He received 1 awards: "Meaningful Use Stage 1 Certification". Dr. Paul D. Dash is a published physician. He published 3 publications, including: 'A Randomized Trial of Ketorolac vs Sumatripan vs Placebo Nasal Spray (KSPN) for Acute Migraine.' Doctor Paul D. Dash, MD accepts Medicare.
NPI NUMBER | 1942237987 | |
NPPES Provider LastName | DASH | |
NPPES Provider FirstName | PAUL | |
NPPES Provider ZIPCode | 212870005 | |
NPPES Provider State | MD | |
Specialty Description | Neurology | |
Total Claim Count | 905.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 16.0 | |
Percent Opioid Claims | 1.77 |
National Provider Identifier [NPI] | 1942237987 |
Last Name Of The Provider | DASH |
First Name Of The Provider | PAUL |
View All |
Dr. Melissa J. Armstrong, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Kathryn Wagner, MD | |
Dr. Peter A. Calabresi, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Lyle W. Ostrow, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Daniel R. Gold, MD | |
Dr. Steven F. Manekin, MD | |
Dr. Jessica L. Klein, MD | |
Dr. Varun Shandal, MD | |
Dr. Mohsen Pirastehfar, MD | |
Dr. Wendy Ziai, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Antonio G. Remollino |